MolNFT v1 · #177357 · protein
Cryo-EM structure of anagrelide-induced PDE3A-SLFN12 complex
7EG0: “Cryo-EM structure of anagrelide-induced PDE3A-SLFN12 complex”. Electron microscopy, 3 ligands (J33, MG, ZN). MolNFT v1 #177357 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7EG0
- Type
- protein
- Length
- 1,878 residues
- Chains
- 4
- Method
- electron microscopy
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- Q14432, Q8IYM2
- Ligands
- J33, MG, ZN
Structure
electron microscopy · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, C | — | protein | 372 | — | Q14432 |
| B, D | — | protein | 567 | — | Q8IYM2 |
Ligands and binding sites
- J33 · 6,7-bis(chloranyl)-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one · ligand · 2 copies · chains A, C
- MG · Magnesium ion · metal · 4 copies · chains A, C
- ZN · Zinc ion · metal · 2 copies · chains B, D
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7EG0 · Cryo-EM structure of anagrelide-induced PDE3A-SLFN12 complex · the same entry in another collection · chain A against A, TM-score 1.00
- Q14432 · AlphaFold monomer V2.0 prediction for cgmp-inhibited 3',5'-cyclic phosphodiesterase a… · a predicted model of the same protein · chain A against A, TM-score 0.99
- Q8IYM2 · AlphaFold monomer V2.0 prediction for schlafen family member 12 (Q8IYM2) · a predicted model of the same protein · chain B against A, TM-score 0.90
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q14432
- Every structure of UniProt Q8IYM2
- Elsewhere: RCSB PDB 7EG0 · PDBe 7EG0 · UniProt Q14432 · UniProt Q8IYM2
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.